Default: Oncology

ISSN: 0030-2414

Journal Home

Journal Guideline

Oncology Q2 Unclaimed

S. Karger AG Switzerland
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Oncology is a journal indexed in SJR in Medicine (miscellaneous) and Oncology with an H index of 104. It has an SJR impact factor of 0,856 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,856.

Oncology focuses its scope in these topics and keywords: patients, cancer, breast, lobular, levelsherneu, metastases, metastasis, oncoprotein, ovarian, overexpression, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

Oncology

0,856

SJR Impact factor

104

H Index

65

Total Docs (Last Year)

292

Total Docs (3 years)

1788

Total Refs

929

Total Cites (3 years)

286

Citable Docs (3 years)

3.21

Cites/Doc (2 years)

27.51

Ref/Doc

Comments

No comments ... Be the first to comment!

Aims and Scope


patients, cancer, breast, lobular, levelsherneu, metastases, metastasis, oncoprotein, ovarian, overexpression, oxaliplatin, phosphatase, acknowledgement, prognostic, relation, retrospective, review, significance, significancea, doseescalation, advanced, affect, alkaline, antigen, aqp, australia, cancerhepatocellular, carcinoma, abdominal, early, epithelial, evaluation, expression, extrahepatic, impact, incidence,



Best articles by citations

Decision Making Criteria in Oncology

View more

Molecular Targets in Cancer Therapy and Their Impact on Cancer Management

View more

Loss of p16/CDKN2A Protein in Epstein-Barr Virus-Associated Gastric Carcinoma

View more

Loss of p27 Expression Is Associated with Poor Prognosis in Stage I-II Pancreatic Cancer

View more

Hyperimmunoglobulinemia D following Cancer Chemotherapy

View more

Skp2 and Jab1 Expression Are Associated with Inverse Expression of p27KIP1 and Poor Prognosis in Oral Squamous Cell Carcinomas

View more

Hemolytic-Uremic Syndrome during Therapy with Estramustine Phosphate for Advanced Prostatic Cancer

View more

Pharmacology of Ifosfamide

View more

Changes in Apoptosis and Mitotic Index, p53 and Ki67 Expression in Various Types of Oral Leukoplakia

View more

Flow Cytometry and Squamous Cell Carcinoma of the Maxillary Sinus: A Possible Prognostic Indicator for Multimodality Intervention

View more

High Impact of Histopathological Remission for Prognosis after Perioperative Chemotherapy with ECF and ECF-Like Regimens for Gastric and Gastroesophageal Adenocarcinoma

View more

Frequent Amplification of C-erbB2 (HER-2/Neu) Oncogene in Cervical Carcinoma as Detected by Non-Fluorescence in situ Hybridization Technique on Paraffin Sections

View more
SHOW MORE ARTICLES

nm23 in the Primary and Metastatic Sites of Gastric Carcinoma

View more

Rivizor -A New Third-Generation Aromatase Inhibitor for the Treatment of Advanced Breast Cancer after Tamoxifen Failure

View more

Cyclin D3 Expression, Cell Proliferation and Pathological Stage of Human Primary Colorectal Cancer

View more

Gross Pathologic Types of Hepatocellular Carcinoma in Italy

View more

Inhibition of Tumor Metastasis by Sodium Caffeate and Its Effect on Angiogenesis

View more

Safety and Efficacy of Modified FOLFIRINOX for Advanced Pancreatic Adenocarcinoma: A UK Single-Centre Experience

View more

Comparison of Low-Dose versus Standard-Dose Colony Stimulating Factor in Patients with Chemotherapy-Induced Febrile Neutropenia

View more

Clinicopathological Significance of Stromelysin-3 Expression in Colorectal Cancer

View more

Local Control after Curative Surgery for Cancer of the Extraperitoneal Rectum

View more

Impact of Interval Debulking Surgery on Clinical Outcome in Primary Unresectable FIGO Stage IIIc Ovarian Cancer Patients

View more

Beta-Catenin Expression in Intramucosal Neoplastic Lesions of the Stomach

View more

Chronological Changes in Incidences of Polymorphic Reticulosis in Korea and Japan

View more

FAQS